Easton Pharmaceuticals announced an agreement to secure all of Latin America for the patented vaginal health diagnostic test it expects to launch under the brand name EvaPro.
The agreement is an amendment to its previously executed 50/50 revenue-sharing partnership agreement with BMV Medica SA de C.V. for an exclusive distribution agreement with Common Sense Ltd. of Israel to become the exclusive distributor in Mexico.
Both companies have obtained exclusive distribution rights for the rest of Latin America, except Brazil, from Israel-based Common Sense for their patented product line known as VS-SENSE-OTC and VS-SENSE PRO for the detection of Bacterial Vaginosis (BV) and yeast infections.
The products are sold in the United States through Prestige Brands in CVS, Walgreens and Rite-Aid Drug Stores under their own private label as well as under the Monistat brand, and throughout Canada in Shoppers Drug-Mart and Jean Coutu.
Easton and BMV are preparing regulatory filings in Mexico through contracted, industry regulatory consultants Ackerman Pharma. Additional funds have been set aside toward branding and packaging.
Organizations in this Story
Want to get notified whenever we write about Easton Pharmaceuticals ?
Next time we write about Easton Pharmaceuticals, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.Sign-up for Alerts
- Guatemalan businessman Fernando Jarquín implements vision for development
- Emiliano Salinas cuts ties with NXIVM
- Fernando Jarquin, Guatemala’s Pharmaceutical Innovator and Entrepreneur, Talks Business
- New Colombia Resources says Sannabis test was successful
- Grupo Exito aims to help support Colombia
- Codelco CEO calls for transparency, focus on production goals
- BCP offers tips on choosing master's degree program
- General Tire launches new tire for Andean market
- Latin America talks of boosting pork production, exports @CorferiasBogota
- AIR Worldwide team takes part in wind-engineering conference